Hideki Asanuma

2.5k total citations
61 papers, 2.0k citations indexed

About

Hideki Asanuma is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Hideki Asanuma has authored 61 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 37 papers in Immunology and 12 papers in Infectious Diseases. Recurrent topics in Hideki Asanuma's work include Influenza Virus Research Studies (36 papers), Immune Response and Inflammation (27 papers) and Respiratory viral infections research (12 papers). Hideki Asanuma is often cited by papers focused on Influenza Virus Research Studies (36 papers), Immune Response and Inflammation (27 papers) and Respiratory viral infections research (12 papers). Hideki Asanuma collaborates with scholars based in Japan, United States and China. Hideki Asanuma's co-authors include Shinichi Tamura, Takeshi Kurata, Chikara Aizawa, Yujiro Suzuki, Kazutoshi Matsuo, Takuya Iwasaki, C Aizawa, Takashi Nagamine, S Tamura and Yuji Inaba and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Hideki Asanuma

61 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Asanuma Japan 25 1.1k 1.0k 511 292 151 61 2.0k
Constantino López-Macı́as Mexico 29 1.1k 1.0× 646 0.6× 815 1.6× 545 1.9× 135 0.9× 96 2.5k
Chikara Aizawa Japan 30 1.4k 1.3× 1.3k 1.3× 553 1.1× 379 1.3× 232 1.5× 55 2.6k
Franklin R. Toapanta United States 19 680 0.6× 744 0.7× 448 0.9× 326 1.1× 76 0.5× 35 1.6k
Georgia Deliyannis Australia 20 718 0.7× 592 0.6× 237 0.5× 326 1.1× 84 0.6× 34 1.3k
Tatyana Matrosovich Germany 16 747 0.7× 2.2k 2.1× 857 1.7× 602 2.1× 127 0.8× 26 2.8k
Iana H. Haralambieva United States 33 1.0k 0.9× 1.4k 1.3× 869 1.7× 732 2.5× 58 0.4× 95 2.6k
Masashi Shingai Japan 23 1.7k 1.6× 776 0.7× 691 1.4× 441 1.5× 181 1.2× 56 2.6k
Claire J. P. Boog Netherlands 25 912 0.8× 617 0.6× 266 0.5× 401 1.4× 95 0.6× 83 1.8k
Akira Ainai Japan 25 762 0.7× 772 0.7× 348 0.7× 295 1.0× 123 0.8× 66 1.6k
Alain Lamarre Canada 26 973 0.9× 346 0.3× 397 0.8× 699 2.4× 148 1.0× 63 2.2k

Countries citing papers authored by Hideki Asanuma

Since Specialization
Citations

This map shows the geographic impact of Hideki Asanuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Asanuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Asanuma more than expected).

Fields of papers citing papers by Hideki Asanuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Asanuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Asanuma. The network helps show where Hideki Asanuma may publish in the future.

Co-authorship network of co-authors of Hideki Asanuma

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Asanuma. A scholar is included among the top collaborators of Hideki Asanuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Asanuma. Hideki Asanuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sasaki, Eita, Hideki Asanuma, Haruka Momose, et al.. (2023). Systemically inoculated adjuvants stimulate pDC-dependent IgA response in local site. Mucosal Immunology. 16(3). 275–286. 2 indexed citations
2.
Matsuyama, Shutoku, Masayuki Shirakura, Yasushi Suzuki, et al.. (2023). Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2. Influenza and Other Respiratory Viruses. 17(2). e13093–e13093. 2 indexed citations
3.
Iwata‐Yoshikawa, Naoko, Masatoshi Kakizaki, Takashi Okura, et al.. (2022). Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways. Nature Communications. 13(1). 6100–6100. 65 indexed citations
4.
Sekizuka, Tsuyoshi, Kentaro Itokawa, Tsutomu Kageyama, et al.. (2020). Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak. Proceedings of the National Academy of Sciences. 117(33). 20198–20201. 46 indexed citations
5.
Adachi, Yu, Keisuke Tonouchi, Arnone Nithichanon, et al.. (2019). Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies. Nature Communications. 10(1). 3883–3883. 28 indexed citations
6.
Nakamura, Kazuya, Hitoshi Takahashi, Heidi Trusheim, et al.. (2019). Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus. Vaccine. 37(43). 6526–6534. 6 indexed citations
7.
Sasaki, Eita, Haruka Momose, Hideki Asanuma, et al.. (2018). Development of screening method for intranasal influenza vaccine and adjuvant safety in preclinical study. Biologicals. 55. 43–52. 5 indexed citations
8.
Sasaki, Eita, Haruka Momose, Kazunari Kamachi, et al.. (2017). Evaluation of marker gene expression as a potential predictive marker of leukopenic toxicity for inactivated influenza vaccines. Biologicals. 50. 100–108. 6 indexed citations
9.
Yuasa, N., Haruhiko Ogawa, Kazuhiro Tsukamoto, et al.. (2012). Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody. The Journal of Biochemistry. 151(4). 371–381. 14 indexed citations
10.
Ainai, Akira, Shinichi Tamura, Tadaki Suzuki, et al.. (2011). Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine. Journal of Medical Virology. 84(2). 336–344. 19 indexed citations
11.
Katano, Harutaka, et al.. (2010). A novel real‐time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses. Journal of Medical Virology. 83(2). 322–330. 45 indexed citations
12.
Asanuma, Hideki, et al.. (2010). Immune response to intranasal and intraperitoneal immunization with Kaposi's sarcoma-associated herpesvirus in mice. Vaccine. 28(19). 3325–3332. 6 indexed citations
13.
Miyazawa, Masaki, Masanori Yasuda, Mariko Fujita, et al.. (2008). Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1. Archives of Gynecology and Obstetrics. 279(6). 789–796. 19 indexed citations
14.
Sekine, Shinichi, Kosuke Kataoka, Hideki Asanuma, et al.. (2007). NALT CD11b+ Dendritic Cell Migration Contributes to Induction of Ag Specific Immunity (B111). The Journal of Immunology. 178(1_Supplement). LB23–LB23. 2 indexed citations
15.
Morizono, T., Keiko Sakai, Shinkichi Sato, et al.. (2007). Construction and Characterization of Single-chain Antibodies Against Human Insulin-like Growth Factor-I Receptor from Hybridomas Producing 1H7 or 3B7 Monoclonal Antibody. The Journal of Biochemistry. 143(1). 9–19. 8 indexed citations
16.
Horiuchi, Yutaka, et al.. (2007). Th1/Th2 balance in canine peripheral blood lymphocytes—A flow cytometric study. Veterinary Immunology and Immunopathology. 118(3-4). 179–185. 24 indexed citations
17.
Shimizu, Yoshitaka, Kazuo Yamakami, Munehiro Nakata, et al.. (2003). Protection against Leishmania major infection by oligomannose-coated liposomes. Bioorganic & Medicinal Chemistry. 11(7). 1191–1195. 41 indexed citations
18.
Tsuji, Takao, Takuya Iwasaki, Shin-etsu Kadowaki, et al.. (2001). Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine. Vaccine. 19(15-16). 2071–2079. 23 indexed citations
19.
Matsuo, Kazutoshi, Hideki Asanuma, Hidehiro Takahashi, et al.. (1998). Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine. 16(16). 1544–1549. 94 indexed citations
20.
Tamura, Shinichi, Hideki Asanuma, Yuji Ito, et al.. (1994). Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice. Vaccine. 12(4). 310–316. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Constantino López-Macı́as Breakdown of academic impact, for papers by Chikara Aizawa Breakdown of academic impact, for papers by Franklin R. Toapanta Breakdown of academic impact, for papers by Georgia Deliyannis Breakdown of academic impact, for papers by Tatyana Matrosovich Breakdown of academic impact, for papers by Iana H. Haralambieva Breakdown of academic impact, for papers by Masashi Shingai Breakdown of academic impact, for papers by Claire J. P. Boog Breakdown of academic impact, for papers by Akira Ainai Breakdown of academic impact, for papers by Alain Lamarre
Rankless by CCL
2026